This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of more complex drug molecules. Its structure, featuring both fluorine and hydroxyl groups, makes it a valuable building block for developing active pharmaceutical ingredients (APIs) with enhanced bioavailability and metabolic stability. It is particularly relevant in the creation of anti-inflammatory and analgesic drugs, where the fluorine atoms contribute to increased potency and selectivity. Additionally, the presence of the acetamide group allows for further chemical modifications, enabling the development of targeted therapies for specific diseases. Its application is also being explored in the field of oncology, where it aids in the design of novel chemotherapeutic agents.